{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:34:40Z","timestamp":1777883680869,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574324"],"award-info":[{"award-number":["82574324"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015361","name":"University of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2025HIAS-ZL007"],"award-info":[{"award-number":["2025HIAS-ZL007"]}],"id":[{"id":"10.13039\/501100015361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015361","name":"University of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2025HIAS-ZL018"],"award-info":[{"award-number":["2025HIAS-ZL018"]}],"id":[{"id":"10.13039\/501100015361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015361","name":"University of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2025ZY01022"],"award-info":[{"award-number":["2025ZY01022"]}],"id":[{"id":"10.13039\/501100015361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015361","name":"University of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2024HIAS-C3001"],"award-info":[{"award-number":["2024HIAS-C3001"]}],"id":[{"id":"10.13039\/501100015361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bmcl.2026.130585","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:19:59Z","timestamp":1771028399000},"page":"130585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis and activity evaluation of a novel PPAR\u03b1 agonist based on virtual screening"],"prefix":"10.1016","volume":"135","author":[{"given":"Yutong","family":"Niu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhili","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bmcl.2026.130585_bb0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4062\/biomolther.2021.008","article-title":"Cyclooxygenase-2 inhibitor parecoxib was disclosed as a PPAR-\u03b3 agonist by in silico and in vitro assay","volume":"29","author":"Xiao","year":"2021","journal-title":"Biomol Ther (Seoul)"},{"issue":"19","key":"10.1016\/j.bmcl.2026.130585_bb0010","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","article-title":"Mechanism of action of fibrates on lipid and lipoprotein metabolism","volume":"98","author":"Staels","year":"1998","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130585_bb0015","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.freeradbiomed.2008.12.001","article-title":"Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid mediates protective effects through regulation of the ERK pathway","volume":"46","author":"Iles","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bmcl.2026.130585_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs","volume":"53","author":"Berger","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.bmcl.2026.130585_bb0025","doi-asserted-by":"crossref","DOI":"10.3987\/COM-18-S(T)61","article-title":"Unexpected emergence of luciferase-inhibitory activity during structural development study of Phenyloxadiazole-based Ppar ligands","volume":"97","author":"Ohgane","year":"2018","journal-title":"Heterocycles"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130585_bb0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis","volume":"116","author":"Lefebvre","year":"2006","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.bmcl.2026.130585_bb0035","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.3390\/ijms19082189","article-title":"The opportunities and challenges of peroxisome proliferator-activated receptors ligands in clinical drug discovery and development","volume":"19","author":"Hong","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130585_bb0040","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/ijms19041197","article-title":"PPAR agonists and metabolic syndrome: an established role?","volume":"19","author":"Botta","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.bmcl.2026.130585_bb0045","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1111\/dom.13370","article-title":"P465L-PPAR\u03b3 mutation confers partial resistance to the hypolipidaemic action of fibrates","volume":"20","author":"Rodriguez-Cuenca","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130585_bb0050","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/0735-1097(95)00379-7","article-title":"Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate","volume":"26","author":"Seiler","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130585_bb0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjcard.2014.10.018","article-title":"Effects of niacin, statin, and fenofibrate on circulating proprotein convertase subtilisin\/Kexin type 9 levels in patients with dyslipidemia","volume":"115","author":"Khera","year":"2014","journal-title":"Am J Cardiol"},{"issue":"15","key":"10.1016\/j.bmcl.2026.130585_bb0060","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1161\/01.CIR.101.15.1773","article-title":"Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus","volume":"101","author":"Evans","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130585_bb0065","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/me.2002-0217","article-title":"Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator","volume":"17","author":"Berger","year":"2003","journal-title":"Mol Endocrinol"},{"issue":"16","key":"10.1016\/j.bmcl.2026.130585_bb0070","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1016\/j.bmcl.2007.05.066","article-title":"Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor alpha agonists","volume":"17","author":"Yamazaki","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130585_bb0075","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1475-2840-12-82","article-title":"Selective peroxisome proliferator-activated receptor \u03b1 modulators (SPPARM\u03b1): the next generation of peroxisome proliferator-activated receptor \u03b1-agonists","volume":"12","author":"Fruchart","year":"2013","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130585_bb0080","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.apsb.2022.02.004","article-title":"Crosstalk between CYP2E1 and PPAR\u03b1 substrates and agonists modulate adipose browning and obesity","volume":"12","author":"Zhang","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"10.1016\/j.bmcl.2026.130585_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101727","article-title":"PPAR\u03b1 ligand-binding domain structures with endogenous fatty acids and fibrates","volume":"23","author":"Kamata","year":"2020","journal-title":"iScience"},{"issue":"9","key":"10.1016\/j.bmcl.2026.130585_bb0090","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1021\/acs.jcim.1c00640","article-title":"Maximum common substructure searching in combinatorial make-on-demand compound spaces","volume":"62","author":"Schmidt","year":"2022","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmcl.2026.130585_bb0095","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.csbj.2021.05.018","article-title":"Scaffold fragmentation and substructure hopping reveal potential, robustness, and limits of computer-aided pattern analysis (C@PA)","volume":"19","author":"Namasivayam","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"issue":"1\u20133","key":"10.1016\/j.bmcl.2026.130585_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10.1016\/j.bmcl.2026.130585_bb0105","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130585_bb0110","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.drudis.2019.03.015","article-title":"ADMET modeling approaches in drug discovery","volume":"24","author":"Ferreira","year":"2019","journal-title":"Drug Discov Today"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130585_bb0115","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130585_bb0120","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130585_bb0125","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field","volume":"6","author":"Shivakumar","year":"2010","journal-title":"J Chem Theory Comput"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:54:25Z","timestamp":1777600465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":25,"alternative-id":["S0960894X26000521"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130585","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and activity evaluation of a novel PPAR\u03b1 agonist based on virtual screening","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130585"}}